흡수성 피브린 실란트 패치 시장 : 용도별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Absorbable Fibrin Sealant Patch Market By Application , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,248,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,465,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

흡수성 피브린 실란트 패치 시장

흡수성 피브린 실란트 패치 시장은 2023년 3억 달러로 평가되며 2024년부터 2033년까지 연평균 7.8% 성장하여 2033년에는 7억 달러에 달할 것으로 예상됩니다.

흡수성 피브린 실란트 패치는 출혈을 조절하고 조직 치유를 촉진하기 위해 수술 절차에 사용되는 무균 물체입니다. 흡수성 피브린 실란트 패치는 말 콜라겐 스펀지와 피브리노겐 및 트롬빈으로 구성된 생분해 성 패치입니다. 패치의 제형은 시간이 지남에 따라 체내에 흡수되어 벗겨낼 필요가 없으며, 감염의 위험도 줄일 수 있습니다. 실란트 패치는 기존의 스테이플이나 봉합으로 지혈이 어렵거나 불충분한 수술에 주로 사용됩니다.

심혈관, 정형외과 및 일반적인 건강 합병증의 유병률 증가로 인한 전 세계 외과 수술의 증가는 흡수성 섬유소 실란트 패치 시장의 주요 촉진제입니다. 또한, 최소침습 수술의 인기가 급증하면서 회복 후 합병증을 제거하기 위해 실란트 패치의 채택이 증가하고 있습니다. 새로운 트렌드로서 실란트 패치는 양면에서 똑같이 활발하고 효과적이며 견인력을 얻고 있습니다. 기존 패치와 비교하여 새로운 실란트 패치는 평균 6배 빠른 속도로 30분 만에 출혈이 멈추는 것으로 보고되고 있습니다.

그러나 실란트 패치를 사용하는 수술 절차의 비용은 전통적인 수술 절차에 비해 상당히 높기 때문에 일부 사람들은 실란트 패치를 선호하지 않습니다. 이는 흡수성 피브린 실란트 패치 시장의 큰 억제요인으로 작용하고 있습니다. 반대로 실란트 패치의 지속적인 발전은 시장 확대에 유리한 기회를 제공할 것으로 예상됩니다. 영국 과학 저널 Nature에 게재된 연구에 따르면, 차세대 패치가 설계되고 있으며, 즉각적인 접착력을 제공하고, 빠른 광 투영과 호환되며, 치료제를 전달할 수 있는 차세대 패치가 개발될 것으로 예상됩니다.

부문 리뷰

흡수성 피브린 실란트 패치 시장은 용도, 최종사용자, 지역으로 분류됩니다. 용도별로는 일반 외과, 심혈관 외과, 상처 관리, 정형외과, 비뇨기과, 안과, 기타로 나뉩니다. 최종사용자별로는 병원 및 클리닉, 외래 수술 센터, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.

주요 조사 결과

용도별로는 기타 부문이 흡수성 피브린 실란트 패치 시장을 주도하고 있습니다.

최종사용자별로는 병원 및 클리닉이 높은 점유율을 차지하고 있습니다.

지역별로는 북미가 2033년까지 가장 높은 수익을 올릴 것으로 예상됩니다.

이 보고서는 사용자 정의가 가능합니다.

• 규제 가이드라인
• 고객의 관심사에 따른 기업 프로파일 추가
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 개요 확장 목록
• 과거 시장 데이터
• 주요 기업의 세부 정보(위치, 연락처, 공급업체/벤더 네트워크 등 포함, 엑셀 형식)

목차

제1장 소개

제2장 주요 요약

제3장 시장 상황

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 흡수성 피브린 실란트 패치 시장 : 용도별

• 시장 개요
• 일반외과
• 심혈관외과
• 창상 관리
• 정형외과
• 비뇨기외과
• 안과외과
• 기타

제5장 흡수성 피브린 실란트 패치 시장 : 최종사용자별

• 시장 개요
• 병원 및 진료소
• 외래 수술 센터
• 기타

제6장 흡수성 피브린 실란트 패치 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 흡수성 피브린 실란트 패치 시장
  • 캐나다의 흡수성 피브린 실란트 패치 시장
  • 멕시코의 흡수성 피브린 실란트 패치 시장
• 유럽
  • 주요 시장 동향과 기회
  • 독일의 흡수성 피브린 실란트 패치 시장
  • 프랑스의 흡수성 피브린 실란트 패치 시장
  • 영국의 흡수성 피브린 실란트 패치 시장
  • 이탈리아의 흡수성 피브린 실란트 패치 시장
  • 스페인의 흡수성 피브린 실란트 패치 시장
  • 기타 유럽의 흡수성 피브린 실란트 패치 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 일본의 흡수성 피브린 실란트 패치 시장
  • 중국 흡수성 피브린 실란트 패치 시장
  • 인도의 흡수성 피브린 실란트 패치 시장
  • 호주의 흡수성 피브린 실란트 패치 시장
  • 한국의 흡수성 피브린 실란트 패치 시장
  • 기타 아시아태평양의 흡수성 피브린 실란트 패치 시장
• 라틴아메리카, 중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 흡수성 피브린 실란트 패치 시장
  • 사우디아라비아의 흡수성 피브린 실란트 패치 시장
  • 남아프리카공화국의 흡수성 피브린 실란트 패치 시장
  • 기타 라틴아메리카, 중동 및 아프리카의 흡수성 피브린 실란트 패치 시장

제7장 경쟁 상황

• 소개
• 주요 성공 전략
• 주요 10개사 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제8장 기업 개요

• Johnson And Johnson
• Baxter International Inc
• Takeda Pharmaceutical Company Limited
• Becton, Dickinson And Company.
• Corza Medical
• LifeBond Ltd
• Surgical Specialties Corporation
• Biegler GmbH
• Cohera Medical Inc
• Integra LifeSciences Corporation

ksm

영문 목차

영문목차

Absorbable Fibrin Sealant Patch Market

The absorbable fibrin sealant patch market was valued at $0.3 billion in 2023 and is projected to reach $0.7 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

An absorbable fibrin sealant patch is a sterile object used in surgical procedures to control bleeding and promote tissue healing. It is a biodegradable patch comprising of equine collagen sponge along with fibrinogen and thrombin, elements which are the key players in the natural blood clotting mechanism of the body. The formulation of the patch involves absorption by the body over time, hence eradicating the need for removal and reducing the risk of infections. The sealant patch is significantly administered during surgeries in which conventional stapling or suturing is difficult or insufficient for hemostasis.

Rise in the conduction of surgical procedures across the globe due to increase in prevalence of cardiovascular, orthopedic, and general health complications is a key driver of the absorbable fibrin sealant patch market. Moreover, surge in the popularity of minimally invasive operations is boosting the adoption of sealant patches as they eliminate the post-recovery intricacies. As an emerging trend, sealant patches that are equally active and effective on both sides are acquiring traction. When compared to the conventional patches, the new sealant patches are reported to be quick by an average of six times, ceasing bleeding in 30 minutes.

However, the cost of surgical procedures involving the use of sealant patches is significantly high as compared to the traditional surgeries, which deters several individuals from preferring them. This acts a major restraint for the absorbable fibrin sealant patch market. On the contrary, constant advancements in sealant patches are expected to present lucrative opportunities for market expansion. According to a study published in Nature, a British scientific journal, next generation of patches are being designed that are projected to provide instant adhesion, possess compatibility with rapid photo-projection, and have the potential to deliver therapeutics.

Segment Review

The absorbable fibrin sealant patch market is segmented into application, end user, and region. On the basis of application, the market is divided into general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgery, ophthalmic surgery, and others. As per end user, it is classified into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of application, the others segment dominates the absorbable fibrin sealant patch market.

As per end user, the hospitals & clinics segment holds a high share of the market.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global absorbable fibrin sealant patch market include Johnson & Johnson, Baxter International Inc, Takeda Pharmaceutical Company Limited, Becton, Dickinson and Company, Corza Medical, LifeBond Ltd, Surgical Specialties Corporation, Biegler GmbH, Cohera Medical Inc, and Integra LifeSciences Corporation. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Application

• General Surgery
• Cardiovascular Surgery
• Wound Management
• Orthopedic Surgery
• Urological Surgery
• Ophthalmic Surgery
• Others

By End User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Johnson & Johnson
• Baxter International Inc
• Takeda Pharmaceutical Company Limited
• Becton, Dickinson and Company.
• Corza Medical
• LifeBond Ltd
• Surgical Specialties Corporation
• Biegler GmbH
• Cohera Medical Inc
• Integra LifeSciences Corporation

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Application
• 4.2. General Surgery
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Cardiovascular Surgery
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. Wound Management
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country
• 4.5. Orthopedic Surgery
  • 4.5.1. Key Market Trends, Growth Factors and Opportunities
  • 4.5.2. Market Size and Forecast, By Region
  • 4.5.3. Market Share Analysis, By Country
• 4.6. Urological Surgery
  • 4.6.1. Key Market Trends, Growth Factors and Opportunities
  • 4.6.2. Market Size and Forecast, By Region
  • 4.6.3. Market Share Analysis, By Country
• 4.7. Ophthalmic Surgery
  • 4.7.1. Key Market Trends, Growth Factors and Opportunities
  • 4.7.2. Market Size and Forecast, By Region
  • 4.7.3. Market Share Analysis, By Country
• 4.8. Others
  • 4.8.1. Key Market Trends, Growth Factors and Opportunities
  • 4.8.2. Market Size and Forecast, By Region
  • 4.8.3. Market Share Analysis, By Country

CHAPTER 5: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By End User
• 5.2. Hospitals And Clinics
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Ambulatory Surgical Centers
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Others
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY REGION

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By Region
• 6.2. North America
  • 6.2.1. Key Market Trends and Opportunities
  • 6.2.2. Market Size and Forecast, By Application
  • 6.2.3. Market Size and Forecast, By End User
  • 6.2.4. Market Size and Forecast, By Country
  • 6.2.5. U.S. Absorbable Fibrin Sealant Patch Market
    • 6.2.5.1. Market Size and Forecast, By Application
    • 6.2.5.2. Market Size and Forecast, By End User
  • 6.2.6. Canada Absorbable Fibrin Sealant Patch Market
    • 6.2.6.1. Market Size and Forecast, By Application
    • 6.2.6.2. Market Size and Forecast, By End User
  • 6.2.7. Mexico Absorbable Fibrin Sealant Patch Market
    • 6.2.7.1. Market Size and Forecast, By Application
    • 6.2.7.2. Market Size and Forecast, By End User
• 6.3. Europe
  • 6.3.1. Key Market Trends and Opportunities
  • 6.3.2. Market Size and Forecast, By Application
  • 6.3.3. Market Size and Forecast, By End User
  • 6.3.4. Market Size and Forecast, By Country
  • 6.3.5. Germany Absorbable Fibrin Sealant Patch Market
    • 6.3.5.1. Market Size and Forecast, By Application
    • 6.3.5.2. Market Size and Forecast, By End User
  • 6.3.6. France Absorbable Fibrin Sealant Patch Market
    • 6.3.6.1. Market Size and Forecast, By Application
    • 6.3.6.2. Market Size and Forecast, By End User
  • 6.3.7. UK Absorbable Fibrin Sealant Patch Market
    • 6.3.7.1. Market Size and Forecast, By Application
    • 6.3.7.2. Market Size and Forecast, By End User
  • 6.3.8. Italy Absorbable Fibrin Sealant Patch Market
    • 6.3.8.1. Market Size and Forecast, By Application
    • 6.3.8.2. Market Size and Forecast, By End User
  • 6.3.9. Spain Absorbable Fibrin Sealant Patch Market
    • 6.3.9.1. Market Size and Forecast, By Application
    • 6.3.9.2. Market Size and Forecast, By End User
  • 6.3.10. Rest of Europe Absorbable Fibrin Sealant Patch Market
    • 6.3.10.1. Market Size and Forecast, By Application
    • 6.3.10.2. Market Size and Forecast, By End User
• 6.4. Asia-Pacific
  • 6.4.1. Key Market Trends and Opportunities
  • 6.4.2. Market Size and Forecast, By Application
  • 6.4.3. Market Size and Forecast, By End User
  • 6.4.4. Market Size and Forecast, By Country
  • 6.4.5. Japan Absorbable Fibrin Sealant Patch Market
    • 6.4.5.1. Market Size and Forecast, By Application
    • 6.4.5.2. Market Size and Forecast, By End User
  • 6.4.6. China Absorbable Fibrin Sealant Patch Market
    • 6.4.6.1. Market Size and Forecast, By Application
    • 6.4.6.2. Market Size and Forecast, By End User
  • 6.4.7. India Absorbable Fibrin Sealant Patch Market
    • 6.4.7.1. Market Size and Forecast, By Application
    • 6.4.7.2. Market Size and Forecast, By End User
  • 6.4.8. Australia Absorbable Fibrin Sealant Patch Market
    • 6.4.8.1. Market Size and Forecast, By Application
    • 6.4.8.2. Market Size and Forecast, By End User
  • 6.4.9. South Korea Absorbable Fibrin Sealant Patch Market
    • 6.4.9.1. Market Size and Forecast, By Application
    • 6.4.9.2. Market Size and Forecast, By End User
  • 6.4.10. Rest of Asia-Pacific Absorbable Fibrin Sealant Patch Market
    • 6.4.10.1. Market Size and Forecast, By Application
    • 6.4.10.2. Market Size and Forecast, By End User
• 6.5. LAMEA
  • 6.5.1. Key Market Trends and Opportunities
  • 6.5.2. Market Size and Forecast, By Application
  • 6.5.3. Market Size and Forecast, By End User
  • 6.5.4. Market Size and Forecast, By Country
  • 6.5.5. Brazil Absorbable Fibrin Sealant Patch Market
    • 6.5.5.1. Market Size and Forecast, By Application
    • 6.5.5.2. Market Size and Forecast, By End User
  • 6.5.6. Saudi Arabia Absorbable Fibrin Sealant Patch Market
    • 6.5.6.1. Market Size and Forecast, By Application
    • 6.5.6.2. Market Size and Forecast, By End User
  • 6.5.7. South Africa Absorbable Fibrin Sealant Patch Market
    • 6.5.7.1. Market Size and Forecast, By Application
    • 6.5.7.2. Market Size and Forecast, By End User
  • 6.5.8. Rest of LAMEA Absorbable Fibrin Sealant Patch Market
    • 6.5.8.1. Market Size and Forecast, By Application
    • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

• 7.1. Introduction
• 7.2. Top Winning Strategies
• 7.3. Product Mapping of Top 10 Player
• 7.4. Competitive Dashboard
• 7.5. Competitive Heatmap
• 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

• 8.1. Johnson And Johnson
  • 8.1.1. Company Overview
  • 8.1.2. Key Executives
  • 8.1.3. Company Snapshot
  • 8.1.4. Operating Business Segments
  • 8.1.5. Product Portfolio
  • 8.1.6. Business Performance
  • 8.1.7. Key Strategic Moves and Developments
• 8.2. Baxter International Inc
  • 8.2.1. Company Overview
  • 8.2.2. Key Executives
  • 8.2.3. Company Snapshot
  • 8.2.4. Operating Business Segments
  • 8.2.5. Product Portfolio
  • 8.2.6. Business Performance
  • 8.2.7. Key Strategic Moves and Developments
• 8.3. Takeda Pharmaceutical Company Limited
  • 8.3.1. Company Overview
  • 8.3.2. Key Executives
  • 8.3.3. Company Snapshot
  • 8.3.4. Operating Business Segments
  • 8.3.5. Product Portfolio
  • 8.3.6. Business Performance
  • 8.3.7. Key Strategic Moves and Developments
• 8.4. Becton, Dickinson And Company.
  • 8.4.1. Company Overview
  • 8.4.2. Key Executives
  • 8.4.3. Company Snapshot
  • 8.4.4. Operating Business Segments
  • 8.4.5. Product Portfolio
  • 8.4.6. Business Performance
  • 8.4.7. Key Strategic Moves and Developments
• 8.5. Corza Medical
  • 8.5.1. Company Overview
  • 8.5.2. Key Executives
  • 8.5.3. Company Snapshot
  • 8.5.4. Operating Business Segments
  • 8.5.5. Product Portfolio
  • 8.5.6. Business Performance
  • 8.5.7. Key Strategic Moves and Developments
• 8.6. LifeBond Ltd
  • 8.6.1. Company Overview
  • 8.6.2. Key Executives
  • 8.6.3. Company Snapshot
  • 8.6.4. Operating Business Segments
  • 8.6.5. Product Portfolio
  • 8.6.6. Business Performance
  • 8.6.7. Key Strategic Moves and Developments
• 8.7. Surgical Specialties Corporation
  • 8.7.1. Company Overview
  • 8.7.2. Key Executives
  • 8.7.3. Company Snapshot
  • 8.7.4. Operating Business Segments
  • 8.7.5. Product Portfolio
  • 8.7.6. Business Performance
  • 8.7.7. Key Strategic Moves and Developments
• 8.8. Biegler GmbH
  • 8.8.1. Company Overview
  • 8.8.2. Key Executives
  • 8.8.3. Company Snapshot
  • 8.8.4. Operating Business Segments
  • 8.8.5. Product Portfolio
  • 8.8.6. Business Performance
  • 8.8.7. Key Strategic Moves and Developments
• 8.9. Cohera Medical Inc
  • 8.9.1. Company Overview
  • 8.9.2. Key Executives
  • 8.9.3. Company Snapshot
  • 8.9.4. Operating Business Segments
  • 8.9.5. Product Portfolio
  • 8.9.6. Business Performance
  • 8.9.7. Key Strategic Moves and Developments
• 8.10. Integra LifeSciences Corporation
  • 8.10.1. Company Overview
  • 8.10.2. Key Executives
  • 8.10.3. Company Snapshot
  • 8.10.4. Operating Business Segments
  • 8.10.5. Product Portfolio
  • 8.10.6. Business Performance
  • 8.10.7. Key Strategic Moves and Developments

관련자료